WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007734) HER-2/NEU DNA VACCINE HAVING ANTI-CANCER ACTIVITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007734    International Application No.:    PCT/KR2003/001400
Publication Date: 22.01.2004 International Filing Date: 15.07.2003
Chapter 2 Demand Filed:    10.02.2004    
IPC:
A61K 39/00 (2006.01)
Applicants: PANGENOMICS CO., LTD. [KR/KR]; #304 Biotechnology Incubating Center, Seoul National University, San 56-1, Shillim-dong, Kwanak-gu, Seoul 151-742 (KR) (For All Designated States Except US).
LEE, Joon Youb [KR/KR]; (KR) (For US Only).
KIM, Dong-Hyeon [KR/KR]; (KR) (For US Only).
CHUNG, Yeonseok [KR/KR]; (KR) (For US Only).
CHANG, Sun-Young [KR/KR]; (KR) (For US Only).
LEE, Kyung-Chul [KR/KR]; (KR) (For US Only).
KANG, Chang-Yuil [KR/KR]; (KR) (For US Only)
Inventors: LEE, Joon Youb; (KR).
KIM, Dong-Hyeon; (KR).
CHUNG, Yeonseok; (KR).
CHANG, Sun-Young; (KR).
LEE, Kyung-Chul; (KR).
KANG, Chang-Yuil; (KR)
Agent: JANG, Seongku; 19th Fl., KEC Building, 275-7, Yangjae-dong, Seocho-ku, Seoul 137-130 (KR)
Priority Data:
10-2002-0041764 16.07.2002 KR
10-2003-0038012 12.06.2003 KR
Title (EN) HER-2/NEU DNA VACCINE HAVING ANTI-CANCER ACTIVITY
(FR) VACCIN A BASE D'ADN HER-2/NEU A ACTIVITE ANTICANCEREUSE
Abstract: front page image
(EN)The present invention relates to human Her-2/neu expressing plasmid constructs having anti-cancer activity and a DNA vaccine comprising same for preventing and/or treating cancer. The Her-2/neu DNA vaccines of the present invention can be effectively used as a therapeutic vaccine in reducing metastasis after tumor surgery or as a prophylactic vaccine for people with genetic high risk.
(FR)L'invention concerne des produits de recombinaison plasmidiques exprimant Her-2/neu humaine ayant une activité anticancéreuse ainsi qu'un vaccin à base d'ADN destiné à prévenir et/ou à traiter le cancer, qui les contient. Les vaccins à base d'ADN Her-2/neu de l'invention peuvent servir de vaccin thérapeutique efficace pour réduire les métastases après une chirurgie tumorale, ou servir de vaccin prophylactique pour les personnes qui présentent un risque génétique élevé.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)